Parathyroid Disorders Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type ( Hyperparathyroidism (HPT), Parathyroid Cancer, Hypoparathyroidism ); Diagnosis ( Blood Tests, Imaging Tests, Urine Tests ); Treatment ( Surgery, Radiation Therapy, Drugs, Others ); End User ( Hospitals and Clinics, Diagnostic Centers, Drug Stores, Pharmacies, Others )
Report Code: TIPRE00007614 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Parathyroid disorders lead to abnormal levels of calcium in the blood that causes brittle bones, kidney stones, fatigue, weakness, and other problems. A parathyroid adenoma is a tumor on one of your parathyroid glands. These are four small glands located near or at the back of your thyroid gland that produce parathyroid hormone (PTH). This hormone helps control the amount of calcium and phosphorus in your blood.
MARKET DYNAMICS
The parathyroid disorders market is anticipated to grow in the market by rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, growing geriatric population is boosting the growth of the market. However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may restrain the market growth.
MARKET SCOPE
The "Parathyroid Disorders Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in parathyroid disorders market with detailed market segmentation by type, diagnosis, treatment, end user and geography. The parathyroid disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in parathyroid disorders market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The parathyroid disorders market is segmented on the basis of type, diagnosis, treatment and by end user. Based on type the market is segmented as hyperparathyroidism (HPT), parathyroid cancer and hypoparathyroidism. On the basis of diagnosis the market is categorized as blood tests, imaging tests and urine tests. On the basis of treatment the market is categorized as surgery, radiation therapy, drugs and others. On the basis of end user the market is categorized as hospitals and clinics, diagnostic centers, drug stores, pharmacies and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in parathyroid disorders market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The parathyroid disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting parathyroid disorders market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the parathyroid disorders market in these regions.
The report covers key developments in the in parathyroid disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in parathyroid disorders market are anticipated to have lucrative growth opportunities in the future with the rising demand for in parathyroid disorders market in the global market. Below mentioned is the list of few companies engaged in the Parathyroid Disorders market.
The report also includes the profiles of key in parathyroid disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Parathyroid disorders lead to abnormal levels of calcium in the blood that causes brittle bones, kidney stones, fatigue, weakness, and other problems. A parathyroid adenoma is a tumor on one of your parathyroid glands. These are four small glands located near or at the back of your thyroid gland that produce parathyroid hormone (PTH). This hormone helps control the amount of calcium and phosphorus in your blood.
MARKET DYNAMICS
The parathyroid disorders market is anticipated to grow in the market by rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, growing geriatric population is boosting the growth of the market. However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may restrain the market growth.
MARKET SCOPE
The "Parathyroid Disorders Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in parathyroid disorders market with detailed market segmentation by type, diagnosis, treatment, end user and geography. The parathyroid disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in parathyroid disorders market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The parathyroid disorders market is segmented on the basis of type, diagnosis, treatment and by end user. Based on type the market is segmented as hyperparathyroidism (HPT), parathyroid cancer and hypoparathyroidism. On the basis of diagnosis the market is categorized as blood tests, imaging tests and urine tests. On the basis of treatment the market is categorized as surgery, radiation therapy, drugs and others. On the basis of end user the market is categorized as hospitals and clinics, diagnostic centers, drug stores, pharmacies and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in parathyroid disorders market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The parathyroid disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting parathyroid disorders market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the parathyroid disorders market in these regions.
The report covers key developments in the in parathyroid disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in parathyroid disorders market are anticipated to have lucrative growth opportunities in the future with the rising demand for in parathyroid disorders market in the global market. Below mentioned is the list of few companies engaged in the Parathyroid Disorders market.
The report also includes the profiles of key in parathyroid disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Alcon Laboratories, Inc.
- Amgen Inc.
- Bayer Healthcare
- Becton
- Dickinson and Company
- Ethicon, Inc.
- Medtronic
- Merck
- Smith & Nephew plc
- Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Parathyroid Disorders Market - By Type
1.3.2 Parathyroid Disorders Market - By Diagnosis
1.3.3 Parathyroid Disorders Market - By Treatment
1.3.4 Parathyroid Disorders Market - By End User
1.3.5 Parathyroid Disorders Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PARATHYROID DISORDERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PARATHYROID DISORDERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PARATHYROID DISORDERS MARKET - GLOBAL MARKET ANALYSIS
6.1. PARATHYROID DISORDERS - GLOBAL MARKET OVERVIEW
6.2. PARATHYROID DISORDERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HYPERPARATHYROIDISM (HPT)
7.3.1. Overview
7.3.2. Hyperparathyroidism (HPT) Market Forecast and Analysis
7.4. PARATHYROID CANCER
7.4.1. Overview
7.4.2. Parathyroid Cancer Market Forecast and Analysis
7.5. HYPOPARATHYROIDISM
7.5.1. Overview
7.5.2. Hypoparathyroidism Market Forecast and Analysis
8. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. BLOOD TESTS
8.3.1. Overview
8.3.2. Blood Tests Market Forecast and Analysis
8.4. IMAGING TESTS
8.4.1. Overview
8.4.2. Imaging Tests Market Forecast and Analysis
8.5. URINE TESTS
8.5.1. Overview
8.5.2. Urine Tests Market Forecast and Analysis
9. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. SURGERY
9.3.1. Overview
9.3.2. Surgery Market Forecast and Analysis
9.4. RADIATION THERAPY
9.4.1. Overview
9.4.2. Radiation Therapy Market Forecast and Analysis
9.5. DRUGS
9.5.1. Overview
9.5.2. Drugs Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DIAGNOSTIC CENTERS
10.4.1. Overview
10.4.2. Diagnostic Centers Market Forecast and Analysis
10.5. DRUG STORES
10.5.1. Overview
10.5.2. Drug Stores Market Forecast and Analysis
10.6. PHARMACIES
10.6.1. Overview
10.6.2. Pharmacies Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. PARATHYROID DISORDERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Parathyroid Disorders Market Overview
11.1.2 North America Parathyroid Disorders Market Forecasts and Analysis
11.1.3 North America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.1.4 North America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.1.5 North America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.1.6 North America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.1.7 North America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.1.7.1 United States Parathyroid Disorders Market
11.1.7.1.1 United States Parathyroid Disorders Market by Type
11.1.7.1.2 United States Parathyroid Disorders Market by Diagnosis
11.1.7.1.3 United States Parathyroid Disorders Market by Treatment
11.1.7.1.4 United States Parathyroid Disorders Market by End User
11.1.7.2 Canada Parathyroid Disorders Market
11.1.7.2.1 Canada Parathyroid Disorders Market by Type
11.1.7.2.2 Canada Parathyroid Disorders Market by Diagnosis
11.1.7.2.3 Canada Parathyroid Disorders Market by Treatment
11.1.7.2.4 Canada Parathyroid Disorders Market by End User
11.1.7.3 Mexico Parathyroid Disorders Market
11.1.7.3.1 Mexico Parathyroid Disorders Market by Type
11.1.7.3.2 Mexico Parathyroid Disorders Market by Diagnosis
11.1.7.3.3 Mexico Parathyroid Disorders Market by Treatment
11.1.7.3.4 Mexico Parathyroid Disorders Market by End User
11.2. EUROPE
11.2.1 Europe Parathyroid Disorders Market Overview
11.2.2 Europe Parathyroid Disorders Market Forecasts and Analysis
11.2.3 Europe Parathyroid Disorders Market Forecasts and Analysis - By Type
11.2.4 Europe Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.2.5 Europe Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.2.6 Europe Parathyroid Disorders Market Forecasts and Analysis - By End User
11.2.7 Europe Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Parathyroid Disorders Market
11.2.7.1.1 Germany Parathyroid Disorders Market by Type
11.2.7.1.2 Germany Parathyroid Disorders Market by Diagnosis
11.2.7.1.3 Germany Parathyroid Disorders Market by Treatment
11.2.7.1.4 Germany Parathyroid Disorders Market by End User
11.2.7.2 France Parathyroid Disorders Market
11.2.7.2.1 France Parathyroid Disorders Market by Type
11.2.7.2.2 France Parathyroid Disorders Market by Diagnosis
11.2.7.2.3 France Parathyroid Disorders Market by Treatment
11.2.7.2.4 France Parathyroid Disorders Market by End User
11.2.7.3 Italy Parathyroid Disorders Market
11.2.7.3.1 Italy Parathyroid Disorders Market by Type
11.2.7.3.2 Italy Parathyroid Disorders Market by Diagnosis
11.2.7.3.3 Italy Parathyroid Disorders Market by Treatment
11.2.7.3.4 Italy Parathyroid Disorders Market by End User
11.2.7.4 Spain Parathyroid Disorders Market
11.2.7.4.1 Spain Parathyroid Disorders Market by Type
11.2.7.4.2 Spain Parathyroid Disorders Market by Diagnosis
11.2.7.4.3 Spain Parathyroid Disorders Market by Treatment
11.2.7.4.4 Spain Parathyroid Disorders Market by End User
11.2.7.5 United Kingdom Parathyroid Disorders Market
11.2.7.5.1 United Kingdom Parathyroid Disorders Market by Type
11.2.7.5.2 United Kingdom Parathyroid Disorders Market by Diagnosis
11.2.7.5.3 United Kingdom Parathyroid Disorders Market by Treatment
11.2.7.5.4 United Kingdom Parathyroid Disorders Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Parathyroid Disorders Market Overview
11.3.2 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis
11.3.3 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.3.5 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Parathyroid Disorders Market
11.3.7.1.1 Australia Parathyroid Disorders Market by Type
11.3.7.1.2 Australia Parathyroid Disorders Market by Diagnosis
11.3.7.1.3 Australia Parathyroid Disorders Market by Treatment
11.3.7.1.4 Australia Parathyroid Disorders Market by End User
11.3.7.2 China Parathyroid Disorders Market
11.3.7.2.1 China Parathyroid Disorders Market by Type
11.3.7.2.2 China Parathyroid Disorders Market by Diagnosis
11.3.7.2.3 China Parathyroid Disorders Market by Treatment
11.3.7.2.4 China Parathyroid Disorders Market by End User
11.3.7.3 India Parathyroid Disorders Market
11.3.7.3.1 India Parathyroid Disorders Market by Type
11.3.7.3.2 India Parathyroid Disorders Market by Diagnosis
11.3.7.3.3 India Parathyroid Disorders Market by Treatment
11.3.7.3.4 India Parathyroid Disorders Market by End User
11.3.7.4 Japan Parathyroid Disorders Market
11.3.7.4.1 Japan Parathyroid Disorders Market by Type
11.3.7.4.2 Japan Parathyroid Disorders Market by Diagnosis
11.3.7.4.3 Japan Parathyroid Disorders Market by Treatment
11.3.7.4.4 Japan Parathyroid Disorders Market by End User
11.3.7.5 South Korea Parathyroid Disorders Market
11.3.7.5.1 South Korea Parathyroid Disorders Market by Type
11.3.7.5.2 South Korea Parathyroid Disorders Market by Diagnosis
11.3.7.5.3 South Korea Parathyroid Disorders Market by Treatment
11.3.7.5.4 South Korea Parathyroid Disorders Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Parathyroid Disorders Market Overview
11.4.2 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis
11.4.3 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.4.5 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Parathyroid Disorders Market
11.4.7.1.1 South Africa Parathyroid Disorders Market by Type
11.4.7.1.2 South Africa Parathyroid Disorders Market by Diagnosis
11.4.7.1.3 South Africa Parathyroid Disorders Market by Treatment
11.4.7.1.4 South Africa Parathyroid Disorders Market by End User
11.4.7.2 Saudi Arabia Parathyroid Disorders Market
11.4.7.2.1 Saudi Arabia Parathyroid Disorders Market by Type
11.4.7.2.2 Saudi Arabia Parathyroid Disorders Market by Diagnosis
11.4.7.2.3 Saudi Arabia Parathyroid Disorders Market by Treatment
11.4.7.2.4 Saudi Arabia Parathyroid Disorders Market by End User
11.4.7.3 U.A.E Parathyroid Disorders Market
11.4.7.3.1 U.A.E Parathyroid Disorders Market by Type
11.4.7.3.2 U.A.E Parathyroid Disorders Market by Diagnosis
11.4.7.3.3 U.A.E Parathyroid Disorders Market by Treatment
11.4.7.3.4 U.A.E Parathyroid Disorders Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Parathyroid Disorders Market Overview
11.5.2 South and Central America Parathyroid Disorders Market Forecasts and Analysis
11.5.3 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.5.4 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.5.5 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.5.7 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Parathyroid Disorders Market
11.5.7.1.1 Brazil Parathyroid Disorders Market by Type
11.5.7.1.2 Brazil Parathyroid Disorders Market by Diagnosis
11.5.7.1.3 Brazil Parathyroid Disorders Market by Treatment
11.5.7.1.4 Brazil Parathyroid Disorders Market by End User
11.5.7.2 Argentina Parathyroid Disorders Market
11.5.7.2.1 Argentina Parathyroid Disorders Market by Type
11.5.7.2.2 Argentina Parathyroid Disorders Market by Diagnosis
11.5.7.2.3 Argentina Parathyroid Disorders Market by Treatment
11.5.7.2.4 Argentina Parathyroid Disorders Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PARATHYROID DISORDERS MARKET, KEY COMPANY PROFILES
13.1. ALCON LABORATORIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER HEALTHCARE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DICKINSON AND COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ETHICON, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MEDTRONIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SMITH AND NEPHEW PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Parathyroid Disorders Market - By Type
1.3.2 Parathyroid Disorders Market - By Diagnosis
1.3.3 Parathyroid Disorders Market - By Treatment
1.3.4 Parathyroid Disorders Market - By End User
1.3.5 Parathyroid Disorders Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PARATHYROID DISORDERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PARATHYROID DISORDERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PARATHYROID DISORDERS MARKET - GLOBAL MARKET ANALYSIS
6.1. PARATHYROID DISORDERS - GLOBAL MARKET OVERVIEW
6.2. PARATHYROID DISORDERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HYPERPARATHYROIDISM (HPT)
7.3.1. Overview
7.3.2. Hyperparathyroidism (HPT) Market Forecast and Analysis
7.4. PARATHYROID CANCER
7.4.1. Overview
7.4.2. Parathyroid Cancer Market Forecast and Analysis
7.5. HYPOPARATHYROIDISM
7.5.1. Overview
7.5.2. Hypoparathyroidism Market Forecast and Analysis
8. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. BLOOD TESTS
8.3.1. Overview
8.3.2. Blood Tests Market Forecast and Analysis
8.4. IMAGING TESTS
8.4.1. Overview
8.4.2. Imaging Tests Market Forecast and Analysis
8.5. URINE TESTS
8.5.1. Overview
8.5.2. Urine Tests Market Forecast and Analysis
9. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. SURGERY
9.3.1. Overview
9.3.2. Surgery Market Forecast and Analysis
9.4. RADIATION THERAPY
9.4.1. Overview
9.4.2. Radiation Therapy Market Forecast and Analysis
9.5. DRUGS
9.5.1. Overview
9.5.2. Drugs Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DIAGNOSTIC CENTERS
10.4.1. Overview
10.4.2. Diagnostic Centers Market Forecast and Analysis
10.5. DRUG STORES
10.5.1. Overview
10.5.2. Drug Stores Market Forecast and Analysis
10.6. PHARMACIES
10.6.1. Overview
10.6.2. Pharmacies Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. PARATHYROID DISORDERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Parathyroid Disorders Market Overview
11.1.2 North America Parathyroid Disorders Market Forecasts and Analysis
11.1.3 North America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.1.4 North America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.1.5 North America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.1.6 North America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.1.7 North America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.1.7.1 United States Parathyroid Disorders Market
11.1.7.1.1 United States Parathyroid Disorders Market by Type
11.1.7.1.2 United States Parathyroid Disorders Market by Diagnosis
11.1.7.1.3 United States Parathyroid Disorders Market by Treatment
11.1.7.1.4 United States Parathyroid Disorders Market by End User
11.1.7.2 Canada Parathyroid Disorders Market
11.1.7.2.1 Canada Parathyroid Disorders Market by Type
11.1.7.2.2 Canada Parathyroid Disorders Market by Diagnosis
11.1.7.2.3 Canada Parathyroid Disorders Market by Treatment
11.1.7.2.4 Canada Parathyroid Disorders Market by End User
11.1.7.3 Mexico Parathyroid Disorders Market
11.1.7.3.1 Mexico Parathyroid Disorders Market by Type
11.1.7.3.2 Mexico Parathyroid Disorders Market by Diagnosis
11.1.7.3.3 Mexico Parathyroid Disorders Market by Treatment
11.1.7.3.4 Mexico Parathyroid Disorders Market by End User
11.2. EUROPE
11.2.1 Europe Parathyroid Disorders Market Overview
11.2.2 Europe Parathyroid Disorders Market Forecasts and Analysis
11.2.3 Europe Parathyroid Disorders Market Forecasts and Analysis - By Type
11.2.4 Europe Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.2.5 Europe Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.2.6 Europe Parathyroid Disorders Market Forecasts and Analysis - By End User
11.2.7 Europe Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Parathyroid Disorders Market
11.2.7.1.1 Germany Parathyroid Disorders Market by Type
11.2.7.1.2 Germany Parathyroid Disorders Market by Diagnosis
11.2.7.1.3 Germany Parathyroid Disorders Market by Treatment
11.2.7.1.4 Germany Parathyroid Disorders Market by End User
11.2.7.2 France Parathyroid Disorders Market
11.2.7.2.1 France Parathyroid Disorders Market by Type
11.2.7.2.2 France Parathyroid Disorders Market by Diagnosis
11.2.7.2.3 France Parathyroid Disorders Market by Treatment
11.2.7.2.4 France Parathyroid Disorders Market by End User
11.2.7.3 Italy Parathyroid Disorders Market
11.2.7.3.1 Italy Parathyroid Disorders Market by Type
11.2.7.3.2 Italy Parathyroid Disorders Market by Diagnosis
11.2.7.3.3 Italy Parathyroid Disorders Market by Treatment
11.2.7.3.4 Italy Parathyroid Disorders Market by End User
11.2.7.4 Spain Parathyroid Disorders Market
11.2.7.4.1 Spain Parathyroid Disorders Market by Type
11.2.7.4.2 Spain Parathyroid Disorders Market by Diagnosis
11.2.7.4.3 Spain Parathyroid Disorders Market by Treatment
11.2.7.4.4 Spain Parathyroid Disorders Market by End User
11.2.7.5 United Kingdom Parathyroid Disorders Market
11.2.7.5.1 United Kingdom Parathyroid Disorders Market by Type
11.2.7.5.2 United Kingdom Parathyroid Disorders Market by Diagnosis
11.2.7.5.3 United Kingdom Parathyroid Disorders Market by Treatment
11.2.7.5.4 United Kingdom Parathyroid Disorders Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Parathyroid Disorders Market Overview
11.3.2 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis
11.3.3 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.3.5 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Parathyroid Disorders Market
11.3.7.1.1 Australia Parathyroid Disorders Market by Type
11.3.7.1.2 Australia Parathyroid Disorders Market by Diagnosis
11.3.7.1.3 Australia Parathyroid Disorders Market by Treatment
11.3.7.1.4 Australia Parathyroid Disorders Market by End User
11.3.7.2 China Parathyroid Disorders Market
11.3.7.2.1 China Parathyroid Disorders Market by Type
11.3.7.2.2 China Parathyroid Disorders Market by Diagnosis
11.3.7.2.3 China Parathyroid Disorders Market by Treatment
11.3.7.2.4 China Parathyroid Disorders Market by End User
11.3.7.3 India Parathyroid Disorders Market
11.3.7.3.1 India Parathyroid Disorders Market by Type
11.3.7.3.2 India Parathyroid Disorders Market by Diagnosis
11.3.7.3.3 India Parathyroid Disorders Market by Treatment
11.3.7.3.4 India Parathyroid Disorders Market by End User
11.3.7.4 Japan Parathyroid Disorders Market
11.3.7.4.1 Japan Parathyroid Disorders Market by Type
11.3.7.4.2 Japan Parathyroid Disorders Market by Diagnosis
11.3.7.4.3 Japan Parathyroid Disorders Market by Treatment
11.3.7.4.4 Japan Parathyroid Disorders Market by End User
11.3.7.5 South Korea Parathyroid Disorders Market
11.3.7.5.1 South Korea Parathyroid Disorders Market by Type
11.3.7.5.2 South Korea Parathyroid Disorders Market by Diagnosis
11.3.7.5.3 South Korea Parathyroid Disorders Market by Treatment
11.3.7.5.4 South Korea Parathyroid Disorders Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Parathyroid Disorders Market Overview
11.4.2 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis
11.4.3 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.4.5 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Parathyroid Disorders Market
11.4.7.1.1 South Africa Parathyroid Disorders Market by Type
11.4.7.1.2 South Africa Parathyroid Disorders Market by Diagnosis
11.4.7.1.3 South Africa Parathyroid Disorders Market by Treatment
11.4.7.1.4 South Africa Parathyroid Disorders Market by End User
11.4.7.2 Saudi Arabia Parathyroid Disorders Market
11.4.7.2.1 Saudi Arabia Parathyroid Disorders Market by Type
11.4.7.2.2 Saudi Arabia Parathyroid Disorders Market by Diagnosis
11.4.7.2.3 Saudi Arabia Parathyroid Disorders Market by Treatment
11.4.7.2.4 Saudi Arabia Parathyroid Disorders Market by End User
11.4.7.3 U.A.E Parathyroid Disorders Market
11.4.7.3.1 U.A.E Parathyroid Disorders Market by Type
11.4.7.3.2 U.A.E Parathyroid Disorders Market by Diagnosis
11.4.7.3.3 U.A.E Parathyroid Disorders Market by Treatment
11.4.7.3.4 U.A.E Parathyroid Disorders Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Parathyroid Disorders Market Overview
11.5.2 South and Central America Parathyroid Disorders Market Forecasts and Analysis
11.5.3 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.5.4 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.5.5 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.5.7 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Parathyroid Disorders Market
11.5.7.1.1 Brazil Parathyroid Disorders Market by Type
11.5.7.1.2 Brazil Parathyroid Disorders Market by Diagnosis
11.5.7.1.3 Brazil Parathyroid Disorders Market by Treatment
11.5.7.1.4 Brazil Parathyroid Disorders Market by End User
11.5.7.2 Argentina Parathyroid Disorders Market
11.5.7.2.1 Argentina Parathyroid Disorders Market by Type
11.5.7.2.2 Argentina Parathyroid Disorders Market by Diagnosis
11.5.7.2.3 Argentina Parathyroid Disorders Market by Treatment
11.5.7.2.4 Argentina Parathyroid Disorders Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PARATHYROID DISORDERS MARKET, KEY COMPANY PROFILES
13.1. ALCON LABORATORIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER HEALTHCARE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DICKINSON AND COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ETHICON, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MEDTRONIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SMITH AND NEPHEW PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Alcon Laboratories, Inc.
2. Amgen Inc.
3. Bayer Healthcare
4. Becton
5. Dickinson and Company
6. Eli Lilly, Ethicon, Inc.
7. Medtronic
8. Merck
9. Smith & Nephew plc
10. Teva Pharmaceutical Industries Ltd.
1. Alcon Laboratories, Inc.
2. Amgen Inc.
3. Bayer Healthcare
4. Becton
5. Dickinson and Company
6. Eli Lilly, Ethicon, Inc.
7. Medtronic
8. Merck
9. Smith & Nephew plc
10. Teva Pharmaceutical Industries Ltd.